Amgen (AMGN) Non-Current Assets (2009 - 2026)

Amgen's Non-Current Assets history runs 18 years deep, the most recent figure standing at $61.0 billion for Q1 2026.

• In Q1 2026, Non-Current Assets fell 2.26% year-over-year to $61.0 billion; the TTM figure through Mar 2026 stood at $246.0 billion (down 2.8% YoY), while the FY2025 annual figure was $61.5 billion, down 2.04% from the prior year.
• Non-Current Assets was $61.0 billion for Q1 2026 at Amgen, down from $61.5 billion in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $66.8 billion in Q4 2023 to a low of $39.6 billion in Q3 2022.
• Historically, Non-Current Assets has averaged $54.3 billion across 5 years, with a median of $61.2 billion in 2025.
• The sharpest annual moves came in 2023 and 2024: Non-Current Assets soared 55.64% in 2023, then declined 6.01% in 2024.
• A 5-year view of Non-Current Assets shows it stood at $42.9 billion in 2022, then jumped by 55.64% to $66.8 billion in 2023, then retreated by 6.01% to $62.8 billion in 2024, then fell by 2.04% to $61.5 billion in 2025, then retreated by 0.81% to $61.0 billion in 2026.
• The last three Non-Current Assets figures came in at $61.0 billion (Q1 2026), $61.5 billion (Q4 2025), and $62.3 billion (Q3 2025), per Business Quant data.